Cardio Diagnostics Holdings, Inc. (CDIO) NASDAQ
1.61
+0.1(+6.62%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.61
+0.1(+6.62%)
Currency In USD
Address
400 N Aberdeen St
Chicago, IL 60642
United States of America (the)
Phone
855 226 9991
Sector
Healthcare
Industry
Biotechnology
Employees
13
First IPO Date
January 14, 2022
| Name | Title | Pay | Year Born |
| Meeshanthini Dogan | Co-Founder, Chief Executive Officer & Director | 312,300 | 1989 |
| Timur Dogan | Chief Technology Officer | 260,300 | 1989 |
| Elisa Michael Luqman | Chief Financial Officer & Principal Accounting Officer | 275,000 | 1964 |
| Robert A. Philibert | Co-Founder, Chief Medical Officer & Director | 0 | 1962 |
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.